These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21542925)

  • 1. Mortality associated with neurofibromatosis 1: a cohort study of 1895 patients in 1980-2006 in France.
    Duong TA; Sbidian E; Valeyrie-Allanore L; Vialette C; Ferkal S; Hadj-Rabia S; Glorion C; Lyonnet S; Zerah M; Kemlin I; Rodriguez D; Bastuji-Garin S; Wolkenstein P
    Orphanet J Rare Dis; 2011 May; 6():18. PubMed ID: 21542925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates.
    Rasmussen SA; Yang Q; Friedman JM
    Am J Hum Genet; 2001 May; 68(5):1110-8. PubMed ID: 11283797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric malignancies in neurofibromatosis type 1: A population-based cohort study.
    Peltonen S; Kallionpää RA; Rantanen M; Uusitalo E; Lähteenmäki PM; Pöyhönen M; Pitkäniemi J; Peltonen J
    Int J Cancer; 2019 Dec; 145(11):2926-2932. PubMed ID: 30724342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1.
    Vasconcelos RAT; Coscarelli PG; Alvarenga RP; Acioly MA
    Arq Neuropsiquiatr; 2017 Jun; 75(6):366-371. PubMed ID: 28658406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.
    Zöller M; Rembeck B; Akesson HO; Angervall L
    Acta Derm Venereol; 1995 Mar; 75(2):136-40. PubMed ID: 7604643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review.
    Zehou O; Fabre E; Zelek L; Sbidian E; Ortonne N; Banu E; Wolkenstein P; Valeyrie-Allanore L
    Orphanet J Rare Dis; 2013 Aug; 8():127. PubMed ID: 23972085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
    Landry JP; Schertz KL; Chiang YJ; Bhalla AD; Yi M; Keung EZ; Scally CP; Feig BW; Hunt KK; Roland CL; Guadagnolo A; Bishop AJ; Lazar AJ; Slopis JM; McCutcheon IE; Torres KE
    JAMA Netw Open; 2021 Mar; 4(3):e210945. PubMed ID: 33734413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989.
    Evans DG; O'Hara C; Wilding A; Ingham SL; Howard E; Dawson J; Moran A; Scott-Kitching V; Holt F; Huson SM
    Eur J Hum Genet; 2011 Nov; 19(11):1187-91. PubMed ID: 21694737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
    Friedrich RE; Hartmann M; Mautner VF
    Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.
    Uusitalo E; Rantanen M; Kallionpää RA; Pöyhönen M; Leppävirta J; Ylä-Outinen H; Riccardi VM; Pukkala E; Pitkäniemi J; Peltonen S; Peltonen J
    J Clin Oncol; 2016 Jun; 34(17):1978-86. PubMed ID: 26926675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1.
    Valeyrie-Allanore L; Ismaïli N; Bastuji-Garin S; Zeller J; Wechsler J; Revuz J; Wolkenstein P
    Br J Dermatol; 2005 Jul; 153(1):79-82. PubMed ID: 16029330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutional NF1 mutations in neurofibromatosis 1 patients with malignant peripheral nerve sheath tumors.
    Kluwe L; Friedrich RE; Peiper M; Friedman J; Mautner VF
    Hum Mutat; 2003 Nov; 22(5):420. PubMed ID: 14517963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.
    Kolberg M; Høland M; Agesen TH; Brekke HR; Liestøl K; Hall KS; Mertens F; Picci P; Smeland S; Lothe RA
    Neuro Oncol; 2013 Feb; 15(2):135-47. PubMed ID: 23161774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
    Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
    Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant peripheral nerve sheath tumors in neurofibromatosis 1.
    King AA; Debaun MR; Riccardi VM; Gutmann DH
    Am J Med Genet; 2000 Aug; 93(5):388-92. PubMed ID: 10951462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
    Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
    Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006).
    Masocco M; Kodra Y; Vichi M; Conti S; Kanieff M; Pace M; Frova L; Taruscio D
    Orphanet J Rare Dis; 2011 Mar; 6():11. PubMed ID: 21439034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncommunicable disease mortality and life expectancy in immigrants to Israel from the former Soviet Union: country of origin compared with host country.
    Ott JJ; Paltiel AM; Becher H
    Bull World Health Organ; 2009 Jan; 87(1):20-9. PubMed ID: 19197401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
    J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years.
    Ingham S; Huson SM; Moran A; Wylie J; Leahy M; Evans DG
    Eur J Cancer; 2011 Dec; 47(18):2723-8. PubMed ID: 21700447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.